286 related articles for article (PubMed ID: 10448826)
1. Coadministration of phenytoin and felbamate: evidence of additional phenytoin dose-reduction requirements based on pharmacokinetics and tolerability with increasing doses of felbamate.
Sachdeo R; Wagner ML; Sachdeo S; Shumaker RC; Lyness WH; Rosenberg A; Ward D; Perhach JL
Epilepsia; 1999 Aug; 40(8):1122-8. PubMed ID: 10448826
[TBL] [Abstract][Full Text] [Related]
2. Discontinuation of phenytoin and carbamazepine in patients receiving felbamate.
Wagner ML; Graves NM; Marienau K; Holmes GB; Remmel RP; Leppik IE
Epilepsia; 1991; 32(3):398-406. PubMed ID: 1904346
[TBL] [Abstract][Full Text] [Related]
3. Tolerability and pharmacokinetics of monotherapy felbamate doses of 1,200-6,000 mg/day in subjects with epilepsy.
Sachdeo R; Narang-Sachdeo SK; Shumaker RC; Perhach JL; Lyness WH; Rosenberg A
Epilepsia; 1997 Aug; 38(8):887-92. PubMed ID: 9579889
[TBL] [Abstract][Full Text] [Related]
4. Effect of felbamate on phenytoin and carbamazepine serum concentrations.
Graves NM; Holmes GB; Fuerst RH; Leppik IE
Epilepsia; 1989; 30(2):225-9. PubMed ID: 2647472
[TBL] [Abstract][Full Text] [Related]
5. Felbamate increases phenytoin but decreases carbamazepine concentrations.
Fuerst RH; Graves NM; Leppik IE; Brundage RC; Holmes GB; Remmel RP
Epilepsia; 1988; 29(4):488-91. PubMed ID: 3391153
[TBL] [Abstract][Full Text] [Related]
6. Felbamate.
Leppik IE
Epilepsia; 1995; 36 Suppl 2():S66-72. PubMed ID: 8784215
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the potential interaction between felbamate and erythromycin in patients with epilepsy.
Sachdeo RC; Narang-Sachdeo S; Montgomery PA; Shumaker RC; Perhach JL; Lyness WH; Rosenberg A
J Clin Pharmacol; 1998 Feb; 38(2):184-90. PubMed ID: 9549651
[TBL] [Abstract][Full Text] [Related]
8. Effect of felbamate on clobazam and its metabolite kinetics in patients with epilepsy.
Contin M; Riva R; Albani F; Baruzzi AA
Ther Drug Monit; 1999 Dec; 21(6):604-8. PubMed ID: 10604819
[TBL] [Abstract][Full Text] [Related]
9. Effect of felbamate on valproic acid disposition in healthy volunteers: inhibition of beta-oxidation.
Hooper WD; Franklin ME; Glue P; Banfield CR; Radwanski E; McLaughlin DB; McIntyre ME; Dickinson RG; Eadie MJ
Epilepsia; 1996 Jan; 37(1):91-7. PubMed ID: 8603632
[TBL] [Abstract][Full Text] [Related]
10. Felbamate in experimental model of status epilepticus.
Mazarati AM; Baldwin RA; Sofia RD; Wasterain CG
Epilepsia; 2000 Feb; 41(2):123-7. PubMed ID: 10691107
[TBL] [Abstract][Full Text] [Related]
11. Topiramate and phenytoin pharmacokinetics during repetitive monotherapy and combination therapy to epileptic patients.
Sachdeo RC; Sachdeo SK; Levy RH; Streeter AJ; Bishop FE; Kunze KL; Mather GG; Roskos LK; Shen DD; Thummel KE; Trager WF; Curtin CR; Doose DR; Gisclon LG; Bialer M
Epilepsia; 2002 Jul; 43(7):691-6. PubMed ID: 12102670
[TBL] [Abstract][Full Text] [Related]
12. Blood-brain barrier penetration of felbamate.
Cornford EM; Young D; Paxton JW; Sofia RD
Epilepsia; 1992; 33(5):944-54. PubMed ID: 1396440
[TBL] [Abstract][Full Text] [Related]
13. Felbamate levels in patients with epilepsy.
Harden CL; Trifiletti R; Kutt H
Epilepsia; 1996 Mar; 37(3):280-3. PubMed ID: 8598188
[TBL] [Abstract][Full Text] [Related]
14. Felbamate: successful development of a new compound for the treatment of epilepsy.
Schmidt D
Epilepsia; 1993; 34 Suppl 7():S30-3. PubMed ID: 8243376
[TBL] [Abstract][Full Text] [Related]
15. Antiepileptic drugs in development: prospects for the near future.
Leppik IE
Epilepsia; 1994; 35 Suppl 4():S29-40. PubMed ID: 8174517
[TBL] [Abstract][Full Text] [Related]
16. The effect of age on the apparent clearance of felbamate: a retrospective analysis using nonlinear mixed-effects modeling.
Banfield CR; Zhu GR; Jen JF; Jensen PK; Schumaker RC; Perhach JL; Affrime MB; Glue P
Ther Drug Monit; 1996 Feb; 18(1):19-29. PubMed ID: 8848816
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous determination of felbamate, primidone, phenobarbital, carbamazepine, two carbamazepine metabolites, phenytoin, and one phenytoin metabolite in human plasma by high-performance liquid chromatography.
Romanyshyn LA; Wichmann JK; Kucharczyk N; Shumaker RC; Ward D; Sofia RD
Ther Drug Monit; 1994 Feb; 16(1):90-9. PubMed ID: 8160262
[TBL] [Abstract][Full Text] [Related]
18. Interaction of felbamate with several other antiepileptic drugs against seizures induced by maximal electroshock in mice.
Gordon R; Gels M; Wichmann J; Diamantis W; Sofia RD
Epilepsia; 1993; 34(2):367-71. PubMed ID: 8453946
[TBL] [Abstract][Full Text] [Related]
19. Felbamate-induced headache.
Ettinger AB; Jandorf L; Berdia A; Andriola MR; Krupp LB; Weisbrot DM
Epilepsia; 1996 May; 37(5):503-5. PubMed ID: 8617182
[TBL] [Abstract][Full Text] [Related]
20. Effect of felbamate on plasma levels of carbamazepine and its metabolites.
Albani F; Theodore WH; Washington P; Devinsky O; Bromfield E; Porter RJ; Nice FJ
Epilepsia; 1991; 32(1):130-2. PubMed ID: 1985822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
